Proposed flat payment rates for 2027 by CMS intensify margin pressures on Medicare Advantage insurers like Clover Health, raising investor concerns about cost management and growth prospects in a tightening regulatory landscape.
A sharp sell-off across digital assets triggered over $1.7 billion in leveraged position liquidations, with Bitcoin and Ethereum leading the losses as market sentiment hits 'extreme fear' levels.
Defense contractor L3Harris Technologies capped off a record 2025 with surging orders and a strategic pivot, announcing plans to take its high-growth Missile Solutions unit public in 2026 while securing a novel $1 billion investment from the Department of War to accelerate production.
Kirby Corporation (NYSE: KEX) reported record annual earnings for 2025, fueled by robust free cash flow and strategic capital returns. While Q4 faced seasonal pressures, management highlighted a late-quarter rebound in inland marine and surging demand in power generation, setting the stage for what they project as a year of steady financial performance in 2026.
Tesla shares face pressure following mixed quarterly results, as surging software subscriptions and ambitious Robotaxi plans clash with declining automotive revenue and soaring capital expenditures.
Despite modest earnings growth, Thai Beverage (SGX:Y92) has seen its share price tumble 40% over five years, leaving long-term investors with a significant total return deficit. We examine the disconnect between fundamentals and market sentiment.
Elon Musk is reportedly exploring a major consolidation of his business empire, with SpaceX considering mergers either with electric vehicle giant Tesla or his artificial intelligence startup xAI, as the space company prepares for a landmark public offering.
Despite reporting a near-doubling of annual net income and raising its 2026 outlook, electronics manufacturer Celestica saw its shares drop sharply Thursday as the market judged its stellar results to be already reflected in the price.
Equity Lifestyle Properties (ELS) reported solid 2025 results with NOI and FFO growth, driven by its core manufactured housing communities. While forecasting further growth for 2026, management acknowledged ongoing fluctuations in its seasonal RV business and provided detailed guidance.
Asian equities faced broad declines Friday, pressured by renewed investor skepticism over the AI investment boom and a sharp pullback in precious metals. The sell-off unfolded against a backdrop of easing oil prices and persistent geopolitical uncertainties.
President Donald Trump is set to announce his nominee for Federal Reserve Chair on Friday, with multiple reports indicating former Fed governor Kevin Warsh is the leading candidate to succeed Jerome Powell, a move already rippling through currency markets.
As OpenAI accelerates toward a potential year-end IPO, Amazon, Microsoft, and Nvidia are in advanced talks to lead a funding round that could exceed $100 billion, reshaping the AI industry's financial and competitive landscape.
Colony Bankcorp (CBAN) reported improved operating performance in Q4 2025, with executives detailing on-track integration of TC Federal and momentum in fee-based businesses. The bank targets a 1.20% return on assets for 2026 and signals appetite for further acquisitions.
President Trump is preparing to nominate former Fed Governor Kevin Warsh to lead the central bank, according to people familiar with the discussions, a move that triggered immediate market reactions as investors assessed the potential policy shift.
A deep dive into the intrinsic value of Aurelius Technologies Berhad (KLSE:ATECH) using a Discounted Cash Flow model suggests a potential disconnect between its market price and fundamental valuation, raising questions for investors.
Axis Capital (AXS) reported robust 2025 results, marked by record premiums and its best underwriting performance in over a decade. While outlining a confident growth trajectory, executives struck a cautious note on cyber insurance and reinsurance headwinds for the coming year.
British pharmaceutical giant AstraZeneca has entered a strategic partnership with China's CSPC Pharmaceutical, committing over $1 billion upfront to co-develop next-generation obesity therapies, signaling intensified competition in the lucrative global weight-loss drug market.
In a turbulent session driven by geopolitical fears, gold staged a historic V-shaped recovery while Bitcoin languished, raising fresh questions about the cryptocurrency's viability as a modern safe haven.
Canadian Pacific Kansas City's mixed Q4 results and 2026 outlook have sparked a tug-of-war between short-term optimism and longer-term concerns, as a new share repurchase program clashes with a year of declining shareholder returns.
Chip designer MaxLinear capped off a transformative 2025 with a strong fourth quarter, reporting 30% full-year revenue growth and positive cash flow ahead of schedule. CEO Kishore Seendripu pointed to surging demand in data center optical interconnects and wireless infrastructure as key catalysts, positioning the company for even faster growth in 2026.
